filings.toolsItem 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
3K characters. Original on sec.gov · Markdown
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
| --- | --- |
The following table includes information about the company’s common stock repurchases during the three-month period ended December 31, 2018.
| Period | Total Number of Shares Purchased(1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Programs(1) | Approximate Dollar Value of Shares that may yet be Purchased Under the Program(1) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| October 1, 2018 through October 31, 2018 | 1,328,099 | $ | 70.35 | 1,328,099 | ||||||||
| November 1, 2018 through November 30, 2018 | 953,202 | $ | 63.28 | 953,202 | ||||||||
| December 1, 2018 through December 31, 2018 (2) | 18,627,352 | $ | 66.23 | 18,627,352 | ||||||||
| Total | 20,908,653 | $ | 66.36 | 20,908,653 | $ | 2,144,034,361 |
| (1) | On July 25, 2012, the company announced that its Board of Directors authorized the company to repurchase up to $2.0 billion of its common stock on the open market or in private transactions. The Board of Directors increased this authority by $1.5 billion in each of November 2016 and February 2018 and by an additional $2.0 billion in November 2018. During the fourth quarter of 2018, the company repurchased approximately 20.9 million shares for $1.4 billion in cash pursuant to this authority through Rule 10b5-1 purchase plans, an accelerated share repurchase program and otherwise. The remaining authorization under this program totaled approximately $2.1 billion at December 31, 2018. This program does not have an expiration date. |
|---|
| (2) | In December 2018, the company entered into an accelerated share repurchase agreement to repurchase an aggregate of $300 million of common stock. In December 2018, 3.6 million shares were initially delivered to the company and the final number of shares and the average purchase price will be determined at the end of the purchase period, which is scheduled to occur in the second quarter of 2019 but may occur earlier in certain circumstances. |
|---|
Baxter common stock is listed on the New York, Chicago and SIX Swiss stock exchanges. The New York Stock Exchange is the principal market on which the company’s common stock is traded under the symbol “BAX”. At January 31, 2019, there were 24,563 holders of record of the company’s common stock.
Performance Graph
The following graph compares the change in Baxter’s cumulative total stockholder return (including reinvested dividends) on Baxter’s common stock with the Standard & Poor’s 500 Composite Index and the Standard & Poor’s 500 Health Care Index over the past five years. Performance through June 30, 2015 has been adjusted for the Baxalta separation which occurred on July 1, 2015.
Previous: Item 4. Mine Safety Disclosures. · Next: Item 6. Selected Financial Data.